Results 121 to 130 of about 799,404 (198)

Targeting NF-κB signaling for HIV latency reversal: Mechanisms, challenges, and therapeutic perspectives. [PDF]

Virus Res
Shirazi MMA, Sadat SM.
europepmc   +1 more source

HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication. [PDF]

Biomedicines, 2023
Andre M, Nair M, Raymond AD.
europepmc   +1 more source

Selection of effective LRAs using a newly designed <i>in vitro</i> HIV latency reactivation protocol: toward future application in HIV samples. [PDF]

Microbiol Spectr
Neri A, Rotili A, Morrocchi E, Pascucci GR, Pighi C, Olivieri G, Betto F, Emili E, Karmakar R, Iaconis D, Lunghini F, Coppola G, Amodio D, Cotugno N, Palma P.   +14 more
europepmc   +1 more source

Innate immune regulation in HIV latency models. [PDF]

Retrovirology, 2022
Olson RM, Gornalusse G, Whitmore LS, Newhouse D, Tisoncik-Go J, Smith E, Ochsenbauer C, Hladik F, Gale M.   +8 more
europepmc   +1 more source

HIV stigma fact sheet [PDF]

Let\u2019s Stop HIV Together raises awareness that we all have a role to play in stopping HIV stigma. When we support people with HIV, we make it easier for them to live healthy lives.visit cdc.gov/tobetherPublication date from document properties.cdc ...

core  

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling. [PDF]

Int J Mol Sci, 2023
Li S, Wang X, Yang Y, Wu X, Zhang L.
europepmc   +1 more source

HIV/AIDS and STD Semiannual Report Incident, Prevalent, and Cumulative AIDS Cases in Kansas as of ... by Date of Report HIV/AIDS in Kansas Biannual Report ... HIV/AIDS in Kansas Annual Report ...

, 2006
"HIV/AIDS and STD Semiannual Report is a publication of the Kansas Department of Health and Environment with funding assistance from the Centers for Disease Control and Prevention" This internet resource contains reports issued throughout the ...
[HIV/AIDS Surveillance Program]
core  

Network Pharmacology-Guided Identification of <i>Candida albicans</i> Secondary Metabolites as Modulators of HIV Latency via Oncogenic Signaling Pathways. [PDF]

Int J Mol Sci
Oduro-Kwateng E, Anyaneji UJ, Fanele A, Ntanzi N, Soliman ME, Mkhwanazi NP.   +5 more
europepmc   +1 more source

Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV. [PDF]

Front Immunol, 2023
Benito JM, Restrepo C, García-Foncillas J, Rallón N.   +3 more
europepmc   +1 more source

Using single cell technologies to understand HIV latency models. [PDF]

Curr Opin HIV AIDS
Huff JS, Browne EP.
europepmc   +1 more source